Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hastings Paul J, Chairman & CEO. Director active across 3 companies, notably Pacira BioSciences, Inc.. Aggregated, 27 filings have been published. Breakdown: 0 buy · 15 sells. Total volume traded: €957k. Activity tracked since 4 June 2021. The latest transaction was filed on 15 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hastings Paul J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
630 shares@ US$62.1911.7% of flowCommon StockSEC:0001209191-21-038878:0
25 of 27 declarations
About Hastings Paul J
HASTINGS PAUL J is Président-Directeur Général. He has 27 filings in total. Across the 27 sampled filings, the most recent activity runs from 2016-01-08 to 2026-01-20, with EUR 0 of buys and EUR 1105230 of sells, and the modal transaction nature is Disposal. The companies mentioned are Nkarta, Inc., Pacira BioSciences, Inc. and OncoMed Pharmaceuticals Inc.